Brazilian President Luiz Inacio Lula da Silva praised the Brazil-India partnership as one of equals, highlighting shared priorities and growing trade. He expressed confidence that bilateral trade could exceed targets. India and Brazil also strengthened cooperation in pharmaceutical and medic
India and Brazil exchanged a Memorandum of Understanding (MoU) to strengthen bilateral cooperation in the field of regulation of pharmaceutical and medical products.
The Government of India has banned the manufacture of the painkiller nimesulide and has also prohibited the sale of all oral formulations of this popular painkiller containing more than 100 mg.
ReLife and Respifresh TR were found to have DEG more than the prescribed standard. While the standard only allows for 0.1 per cent in the medicine, ReLife contained 0.616 per cent and Respifresh TR contained 1.342 per cent, according to officials.